Showing results (1-10 of 3,008) with videos related to
Sort By:
Pageof 301
The American Journal of Gastroenterology|October 16, 1999
Biomarker studies in reversed Barrett's esophagusH Garewal, L Ramsey, P Sharma, et al.JAMA|January 3, 1977
Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. The need for liver biopsyR SamplinerEndoscopy|December 14, 2006
Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter studyP Sharma, N Marcon, S Wani, et al.Analytical and Quantitative Cytology and Histology|March 10, 2001
Karyometry in Barrett's esophagusV D da Silva, J C Prolla, P Sharma, et al.Preventive Medicine|September 1, 1989
Barrett's esophagus: a model premalignant lesion for adenocarcinomaH S Garewal, R SamplinerJournal of Clinical Pharmacology|January 1, 1984
Influence of ascites on tobramycin pharmacokineticsR Sampliner, D Perrier, R Powell, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1994
Demonstration of a field defect in gastric intestinal metaplasia by biological marker analysisH S Garewal, B Fennerty, R Sampliner, et al.Digestive Diseases and Sciences|February 1, 1989
Increase in ornithine decarboxylase activity associated with development of dysplasia in Barrett's esophagusH S Garewal, R Sampliner, D Alberts, et al.Cancer Research|April 1, 1996
Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer riskH Garewal, H Bernstein, C Bernstein, et al.Cancer Genetics and Cytogenetics|October 15, 1989
Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinomaH S Garewal, R Sampliner, Y Liu, et al.Pageof 301